Dr. David Goldberg is an Associate Professor of Medicine in the Division of Digestive Health and Liver Diseases at the University of Miami Miller School of Medicine. Dr. Goldberg completed fellowships in gastroenterology and then transplant hepatology at the Hospital of the University of Pennsylvania from 2008-2013, during which he earned a Master of Science in Clinical Epidemiology. He was then a faculty member at the University of Pennsylvania from 2013-2019, after which he joined the faculty at the University of Miami Miller School of Medicine in 2019.

Dr. Goldberg's uses tools from epidemiology, biostatistics, and health services research to focus on several areas, including: 1) disparities in access-to-care for patients with end-stage liver disease and hepatocellular carcinoma; 2) optimizing allocation of livers for transplantation; 3) using novel biostatistical methods to better characterize donor allograft quality, predict transplant outcomes, and expand access to kidney and liver transplantation; 4) increasing the number of lifesaving organ transplants by transplanting organs from deceased donors with hepatitis C into hepatitis C-negative recipients. Dr. Goldberg has received funding from the National Institutes of Health, private foundations, and the pharmaceutical industry (via investigator-initiated grants). He is currently the PI/Co-PI of two R01 grants funded from the NIDDK/NIH focused on developing new models to estimate the survival benefit of liver transplantation, and to develop better models to predict outcomes of kidney and liver allografts, and a U01 from the NIDDK to perform a multi-center trial of transplanting kidneys from hepatitis C-infected donors into hepatitis C-negative patients. Dr. Goldberg has published more than 100 peer-reviewed publications including first-author papers in the New England Journal of Medicine and JAMA. Dr. Goldberg was the co-PI of the first published clinical trial of transplanting kidneys from Hepatitis C-infected donors into Hepatitis C-negative recipients which was featured on NBC Nightly News and in TIME magazine, and was awarded the AST Innovation Award by the American Society of Transplantation in 2020.